GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Crystalvue Medical 6527.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

72.90

+1.11%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 949.0m

FY2016FY2025

Net income

TWD 147.0m

FY2016FY2025

Free cash flow

−TWD 46.1m

FY2016FY2025

Shareholders' equity

TWD 1.03bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 949.0mTWD 868.0mTWD 824.0mTWD 795.5mTWD 721.6mTWD 504.4mTWD 661.1mTWD 606.3mTWD 493.8mTWD 542.2m
Gross profitTWD 331.9mTWD 299.1mTWD 266.7mTWD 261.7mTWD 211.4mTWD 165.4mTWD 241.1mTWD 187.9mTWD 117.6mTWD 143.3m
Research and developmentTWD 40.3mTWD 45.7mTWD 44.7mTWD 47.0mTWD 49.2mTWD 41.3mTWD 42.8mTWD 38.8mTWD 34.4mTWD 39.0m
Operating incomeTWD 180.9mTWD 145.0mTWD 117.7mTWD 143.0mTWD 88.5mTWD 57.7mTWD 114.1mTWD 77.2mTWD 37.0mTWD 56.8m
Net incomeTWD 147.0mTWD 127.2mTWD 103.4mTWD 115.0mTWD 77.2mTWD 56.6mTWD 91.1mTWD 69.9mTWD 33.6mTWD 49.6m
Diluted earnings per share5.805.044.094.633.082.214.023.081.482.19

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.30bnTWD 1.18bnTWD 1.08bnTWD 1.01bnTWD 938.5mTWD 886.8mTWD 900.5mTWD 631.5mTWD 537.0mTWD 502.3m
Cash and short-term investments—————TWD 461.7mTWD 567.3mTWD 347.5mTWD 305.8mTWD 299.4m
Total liabilitiesTWD 266.8mTWD 246.4mTWD 221.4mTWD 237.3mTWD 219.6mTWD 211.7mTWD 199.0mTWD 169.6mTWD 115.8mTWD 93.2m
Debt—————TWD 43.6mTWD 49.5m———
Shareholders' equityTWD 1.03bnTWD 938.5mTWD 857.1mTWD 775.7mTWD 718.9mTWD 675.1mTWD 701.5mTWD 461.9mTWD 421.3mTWD 409.1m
Shares outstanding25m25m25m25m25m26m23m23m23m23m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 139.1mTWD 153.1mTWD 154.0mTWD 51.8mTWD 63.3mTWD 83.5m—TWD 101.3mTWD 49.9mTWD 67.1m
Capital spending−TWD 185.2m−TWD 132.0m−TWD 8.5m−TWD 9.0m−TWD 352.0m−TWD 103.5m—−TWD 26.1m−TWD 7.5m−TWD 9.5m
Free cash flow−TWD 46.1mTWD 21.0mTWD 145.5mTWD 42.8m−TWD 288.7m−TWD 20.0m—TWD 75.3mTWD 42.5mTWD 57.6m
Dividends paid−TWD 57.0m−TWD 52.3m−TWD 56.8m−TWD 46.3m−TWD 33.4m−TWD 61.9m—−TWD 21.4m−TWD 21.4m−TWD 25.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 217.8mTWD 188.3mTWD 267.2mTWD 200.9mTWD 256.4mTWD 224.5mTWD 223.9mTWD 233.1m
Gross profitTWD 87.5mTWD 75.4mTWD 93.6mTWD 69.4mTWD 88.2mTWD 80.6mTWD 79.2mTWD 82.7m
Operating incomeTWD 45.7mTWD 37.9mTWD 47.9mTWD 35.4mTWD 53.5mTWD 44.0mTWD 36.7mTWD 44.3m
Net incomeTWD 42.3mTWD 33.8mTWD 37.7mTWD 34.7mTWD 37.7mTWD 36.9mTWD 30.0mTWD 33.6m
Diluted earnings per share1.671.331.491.361.491.461.191.33
Cash from operations−TWD 23.0mTWD 65.0mTWD 54.0m—−TWD 15.0mTWD 34.0mTWD 56.0mTWD 81.0m
Capital spending−TWD 29.0m−TWD 80.0m−TWD 27.0m—−TWD 64.0m−TWD 29.0m−TWD 85.0m—
Free cash flow−TWD 52.0m−TWD 15.0mTWD 27.0m—−TWD 79.0mTWD 5.0m−TWD 29.0m—
Total assetsTWD 1.36bnTWD 1.33bnTWD 1.30bn—TWD 1.22bnTWD 1.20bnTWD 1.18bnTWD 1.10bn
DebtTWD 30.0m———————
Shareholders' equityTWD 1.03bnTWD 989.1mTWD 1.03bn—TWD 956.1mTWD 918.4mTWD 938.5mTWD 908.6m

Financial ratios

Data as of 31 Oct 2026

FY2025FY2024FY2023FY2022FY2021
Gross margin35.0%34.5%32.4%32.9%29.3%
Operating margin18.9%18.4%14.6%18.0%12.3%
Net margin15.5%14.6%12.5%14.5%10.7%
Return on equity14.3%13.5%12.1%14.8%10.7%
Return on assets11.3%10.7%9.6%11.4%8.2%
Revenue growth9.3%5.3%3.6%10.2%—
Earnings growth15.6%23.0%-10.1%48.9%—
Current ratio2.45x3.00x3.46x2.90x2.75x
Equity ratio79.4%79.2%79.5%76.6%76.6%
Interest coverage396.17x253.18x147.38x143.72x75.36x
R&D as a share of sales4.2%5.3%5.4%5.9%6.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.1%13.5%7.4%
Operating income8.2%25.7%12.4%
Net income8.5%21.0%11.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin34.7%33.7%33.0%31.8%
Operating margin17.9%17.1%15.7%14.5%
Net margin15.1%14.3%13.4%12.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings13.116.821.210.714.821.418.614.717.019.0
Price to sales2.02.52.71.61.62.42.61.71.21.7

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 24 Jul 2025.

FY2025FY2024FY2023FY2022
Paid in the year2.252.0642.401.848
  • 1050-for-1000 split · 25 Jul 2023

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.